Novartis acquires all remaining rights to GSK’s Ofatumumab
To develop treatments for MS and other autoimmune indications
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Getting the science right
The ‘no pain, no gain’ mantra seems to be finally putting the $25 billion AstraZeneca on the road to recovery, as it continues to…
Rajiv Gandhi NIIPM to conduct sessions on IPR
The training session to create awareness on IPR will be held in Nagpur
A nudge in the right direction
National government-run laboratories are responsible for approving the availability of new drugs in the market. Yet, very few of…
Lupin receives US FDA approval for Fenofibrate tabs
Lupin Pharmaceuticals would commence promoting the product shortly in the US
Lupin has received final approval for its…
Asia Pharma Expo 2016 to be held in Dhaka
The event from January 28 to 30, 2016 will be beneficial to local business associates and international machinery manufacturers…
Global multiple myeloma treatment market value to approach $9 billion by 2021: GBI Research
This will be driven primarily by rising multiple myeloma prevalence as a result of an aging population
The global multiple…
‘India is our jumping off point in Asia’
Over 370,000 patients in India develop solid tumour based cancers annually, that require comprehensive genomic profiling. Cancer…
Pharma sales to grow beyond $1 trillion
Forecasts sales to reach $1.3 trillion by 2018
India foils UK firms’s bid to patent use of turmeric, pine bark and tea for treating hair loss
An attempt by Colgate-Palmolive Co to patent a mouthwash formula made from Indian herbs was also foiled by CSIR-TKDL unit recently